Long-Acting β2-Agonists in Asthma Graeme P. CurrieDaniel K.C. LeeBrian J. Lipworth Current Opinion 09 January 2013 Pages: 647 - 656
Pharmacovigilance during the Pre-Approval Phases Craig G. HartfordKasia S. PetchelPaula Marquez Leading Article 09 January 2013 Pages: 657 - 673
Safety of Etanercept in Psoriasis Jose L. Sánchez CarazoLaura Mahiques SantosVicente Oliver Martinez Review Article 09 January 2013 Pages: 675 - 685
Serious Skin Reactions and Selective COX-2 Inhibitors Deborah LaytonVanessa MarshallSaad AW Shakir Short Communication 09 January 2013 Pages: 687 - 696
Can Decisional Algorithms Replace Global Introspection in the Individual Causality Assessment of Spontaneously Reported ADRs? Ana F. MacedoFrancisco B. MarquesCarlos F. Ribeiro Original Research Article 09 January 2013 Pages: 697 - 702
Effect of Ezetimibe and/or Simvastatin on Coenzyme Q10 Levels in Plasma Heiner K. BertholdAli NainiIoanna Gouni-Berthold Original Research Article 09 January 2013 Pages: 703 - 712
Drug-Induced Thrombocytopenia Maarten J. ten BergAlbert HuismanPatricia M.L.A. van den Bemt Original Research Article 09 January 2013 Pages: 713 - 721
Clinical Risk Management in Dutch Community Pharmacies Henk BuurmaPeter A.G.M De SmetAntoine C.G. Egberts Original Research Article 09 January 2013 Pages: 723 - 732
An Industry Perspective on the Erice Declaration and Risk Minimisation Plans Simon IngateDeborah TranterAndrew Hobbs Correspondence 09 January 2013 Pages: 733 - 734